Drug Shortage Report for INTUNIV XR
| Report ID | 250821 |
| Drug Identification Number | 02409127 |
| Brand name | INTUNIV XR |
| Common or Proper name | Guanfacine hydrochloride extended-release tablets |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GUANFACINE |
| Strength(s) | 3MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | Bottles of 100's tablets |
| ATC code | C02AC |
| ATC description | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-02-20 |
| Actual start date | 2025-02-20 |
| Estimated end date | 2025-05-09 |
| Actual end date | 2025-04-29 |
| Shortage status | Resolved |
| Updated date | 2025-04-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-04-29 | French | Compare |
| v4 | 2025-04-29 | English | Compare |
| v3 | 2025-02-21 | English | Compare |
| v2 | 2025-02-20 | French | Compare |
| v1 | 2025-02-20 | English | Compare |
Showing 1 to 5 of 5